Mast
Energy Developments PLC
(Incorporated in England and
Wales)
(Registration Number:
12886458)
Share code on the LSE:
MAST
ISIN: GB00BMBSCV12
("MED" or "the
Company")
Audited results for the year ended
31 December 2024
Dated 30 April 2025
MAST Energy Developments PLC
('MED' or the 'Company'), is pleased to announce its audited
results for the year ended 31 December 2024. A condensed set of financial statements accompanies this
announcement below while the Company's full Annual Report and
Financial Statements (Audited Annual Report and Accounts for the
year ended 31 December 2024) can be found at the Company's website
at www.med.energy.
The Company's Notice of Annual
General Meeting will be announced separately in due
course.
Overview of key events during the period up to the date of
this report
·
Revenue increased 77% year-on-year, which were
predominantly earned from July 2024 during the last 6 months of the
year, as a result of the comprehensive refurbishment programme
started at the Pyebridge site earlier in 2024 in partnership with
RiverFort Global Opportunities PCC Limited ("RiverFort"), and the
successful completion of the overhaul of two engines at the
Pyebridge site.
·
Loss per share improved significantly with 78%
from 1.51 pence in 2023 to 0.32 pence in 2024.
·
The comprehensive refurbishment programme at
Pyebridge included the overhaul of two engines at the Pyebridge
site and other technical upgrades. The overhauled engines achieved
full commercial operation in July 2024 and December 2024
respectively and are operating at optimum efficiency, providing a
combined 5.4MW of power generation capacity.
·
Company successfully secured alternative funding
under a loan facility for up to £4m with RiverFort further to an
agreement with MED subsidiary Pyebridge Power Ltd ("Pyebridge") on
28 February 2024. This loan facility on which the Company
made three gross drawdowns during 2024 totalling £2,769,297 enabled
the comprehensive refurbishment at Pyebridge. Subsequently,
repayments to the value of £529,969 were made up to year-end, and
cumulative repayments to date totals £637,969.
·
MED's Pyebridge site has secured uninterrupted
Capacity Market contracts to ensure minimum gross profit margin
income totalling c. £1,7m until 2029, in addition to its
trading revenue generation via its PPA with Statkraft.
·
MED entered into a long-term Growth Capital
Partnership with a long-established and successful UK flexible
power developer and operator, Powertree (Holdings) Ltd
("Powertree"). As part of this Partnership, Powertree and ADV 001
Limited (MED's special purpose vehicle ("SPV") holding the Hindlip
Project), signed a comprehensive investment agreement for the
construction of Hindlip to provide capital funding for Hindlip up
to £5m, resulting in the Hindlip site being fully funded with no
further funding obligation from MED.
·
Following a successful turnaround during 2024,
and with the ongoing support of its two new funding partners,
RiverFort and Powertree, MED is now well positioned to grow its
portfolio of MWs in production at some pace to achieve its target
of 300+.
This announcement contains inside information for the
purposes of the UK version of the Market Abuse Regulation (EU No.
596/2014) as it forms part of United Kingdom domestic law by virtue
of the European Union (Withdrawal) Act 2018 ("UK MAR"). Upon the
publication of this announcement, this inside information is now
considered to be in the public domain.
ENDS
For further information please
visit www.med.energy
or contact:
Pieter Krügel
|
info@med.energy
|
Mast Energy Developments
plc
|
CEO
|
Jon Belliss
|
+44 (0)20 7399 9425
|
Novum Securities
|
Corporate Broker
|
Guy Wheatley, CFA
|
+44 (0)74 9398 9014
|
Fortified Securities
|
Corporate Broker
|
DIRECTORS, OFFICERS AND PROFESSIONAL
ADVISERS
BOARD OF DIRECTORS:
|
|
Paul Venter (Non-Executive
Chairman)
|
|
|
Pieter Krügel (Chief Executive
Officer)
|
|
|
|
REGISTERED OFFICE AND
|
|
Salisbury House
|
BUSINESS ADDRESS:
|
|
London Wall
|
|
|
London
|
|
|
EC2M 5PS
|
|
|
|
COMPANY SECRETARY:
|
|
Noel Flannan O'Keeffe
|
|
|
Salisbury House
|
|
|
London Wall
|
|
|
London
|
|
|
EC2M 5PS
|
|
|
|
PLACE OF INCORPORATION:
|
|
England & Wales
|
|
|
|
AUDITORS:
|
|
Crowe U.K. LLP
|
|
|
55 Ludgate Hill
|
|
|
London
|
|
|
EC4M 7JW
|
|
|
|
BROKERS:
|
|
Novum Securities Limited
|
|
|
2nd Floor 57 Berkeley
Square
|
|
|
London
|
|
|
W1J 6ER
|
|
|
|
|
|
Fortified
Securities
|
|
|
9 Dalton House
|
|
|
60 Windsor Avenue
|
|
|
London
|
|
|
SW19 2RR
|
|
|
|
REGISTRAR:
|
|
MUFG Corporate Markets
|
|
|
Unit 10, Central Square
|
|
|
29 Wellington Street
|
|
|
Leeds
|
|
|
LS1 4DL
|
|
|
|
SOLICITORS:
|
|
Druces LLP
|
|
|
Salisbury House
|
|
|
London Wall
|
|
|
London
|
|
|
EC2M 5PS
|
|
|
|
PRINCIPLE BANKERS:
|
|
Barclays Bank PLC
|
|
|
1 Churchill Place
|
|
|
Canary Wharf
|
|
|
London E14 5HP
|
|
|
|
STOCK EXCHANGE LISTING:
|
|
London Stock Exchange: Main Market
(Share code: MAST)
|
|
|
|
WEBSITE:
|
|
www.med.energy
|
|
|
|
DATE OF INCORPORATION:
|
|
17 September 2020
|
|
|
|
REGISTERED NUMBER:
|
|
12886458
|
CHAIRMANS REPORT
I am pleased to provide a review
of MAST Energy Developments PLC ("MED" or the "Company") and its
subsidiaries (collectively, the "Group") activities and audited
financial statements for the year ended 31 December
2024.
The past year has seen the Company
turn a corner in pursuing its business strategy to expand its
operations in the flexible power generation market in the United
Kingdom following some set-backs in 2023 beyond its expectation or
control, which saw the Company terminate the joint venture
agreements with two investors because of failure of said investors
to fulfil their contractual obligations. In early 2024, the Company
successfully secured alternative funding under a loan facility for
up to £4m with institutional investor, RiverFort Global
Opportunities PCC Limited ("RiverFort") further to an agreement
signed with MED subsidiary Pyebridge Power Ltd ("Pyebridge") on 28
February 2024. This loan facility on which the Company made
three gross drawdowns during 2024 totalling £2,769,297 enabled the
Company to pursue a comprehensive refurbishment programme and
successful completion of the overhaul of two of the engines at our
Pyebridge flexible power generation site. The Company repaid the
Pyebridge loan facility owing to RiverFort to the value of £529,969
during the year, resulting in a net balance owing at year-end
amounting to £2,239,328. The results of the positive progress at
Pyebridge can clearly be seen from the Company's regular RNS
announcements throughout 2024 to date. Most notably, they report
significantly improved operating performance and enhanced revenue
generation at Pyebridge. Pyebridge also benefited from extended
periods of low winds during the last quarter of 2024 which sent UK
power prices to a multi-year high, with the intraday price for
electricity surging to c. £600 per MWh during December
2024.
Following successful
pre-qualification for additional Capacity Market ("CM") T-1 and T-4
contracts during the assessment window in August 2024, and the
implementation of a robust CM auction bid strategy, for the first
time Pyebridge has now successfully secured both contracts at its
maximum generation capacity permissible under the CM rules. The
recent CM T-4 auction cleared at £60,000 per MW/year, and the CM
T-1 auction cleared at £20,000 per MW/year. This means that
Pyebridge now has uninterrupted CM contracts until 2029 with a
cumulative total guaranteed gross profit income value of c. £1.73m,
over and above its trading income through the Statkraft Power
Purchase Agreement ("PPA") and Embedded Benefits.
Since the signing of the loan
facility with RiverFort in February 2024, I am glad to report that
our relationship has deepened and broadened over 2024 culminating
in the signing of a Project Finance Framework Agreement in
November 2024 providing for RiverFort to support MED to
procure and secure project finance funding in order to grow its
portfolio of in production to 300+ MW's, and further provide MED
with certain financial advisory support services. Commensurate with
the signing of the Project Finance Framework Agreement, we also
announced the sale of our greenfield Rochdale Project at a premium
to the initial acquisition cost. This sale was in line with our
refocused strategy to acquire existing constructed or advanced
sites which have a lower total investment cost and shorter time to
production and income generation than earlier stage development
sites. The sale also provided additional cashflow to the Company to
expedite its refocused acquisition strategy and for general working
capital purposes.
In addition to the Rochdale sale,
we have continued to examine how we can best achieve value from our
remaining three early construction and development sites,
Bordesley, Hindlip and Stather while acquiring additional more
advanced projects in line with our refocused strategy as mentioned
above. In this regard, I am pleased to reflect on MED's
new Growth Capital Partnership with long-established and successful
UK flexible power developer and operator, Powertree (Holdings) Ltd
("Powertree"), to form a long-term partnership with MED and deploy
capital into the portfolio of development flexible power generation
projects that MED owns or acquires, starting with Hindlip. As
part of this Growth Capital Partnership, Powertree and ADV 0001
Limited (MED's SPV holding the Hindlip Project), signed an interim
finance facility agreement for an initial advance of up to £70,000
of which MED availed of the full amount to cover some of Hindlip
site's on-going development costs. Subsequent to the signing of the
finance facility MED has now entered a comprehensive investment
agreement with Powertree for the construction of Hindlip under the
terms of the Growth Capital Partnership. This comprises an
investment agreement and a revision of the existing finance
facility to provide capital funding for Hindlip up to £5m,
resulting in the Hindlip site being fully funded with no further
funding obligation from MED. The Growth Capital Partnership, which
we expect will be extended to MED's other development and pipeline
projects should assist with accelerating the timeframe to our
objective to reach a 300+ MW portfolio acquiring, developing and
operating multiple small-scale flexible power generation plants
across the UK. In terms of pipeline projects, MED and its partners
continue to identify potential acquisition opportunities with the
objective to grow MED's portfolio of MWs in production at some
pace.
With regard to corporate matters,
following MED's successful agreement on the reprofiling of the
outstanding balances on MED's two existing loan facilities held
with RiverFort in May 2023, the Company paid down £325,000 on the
outstanding balance in May 2024 via a director loan purchase
agreement and a placing, and also secured funding of £325,000 via a
new non-convertible fixed term loan with RiverFort. The placing,
which was facilitated by the company's broker, Novum Securities,
was at a price of 0.20p per share resulting in the issue of an
additional 162,500,000 shares during 2024. I am also pleased to
welcome Fortified Securities who were appointed in November 2024 as
an additional corporate broker. Together with Novum Securities. I
am confident that they will greatly assist the Company with its
future funding requirements. Towards the end of 2024 we also saw
Louis Coetzee and Dominic Traynor step-down and retire as directors
of MED to pursue other business interests, and I would like to
thank them for their significant contributions to the development
of the Company while they served as directors.
I would like to extend a special
word of thanks and appreciation on behalf of the Company and its
board of directors to RiverFort, which was instrumental in ensuring
MED's successful business turnaround during 2024 and continues to
provide significant support to the Group.
As I write, changes in the global
geopolitical environment are rapid, with the threat of a global
tariff war on the horizon as well as uncertainty on the outcomes of
conflicts in Ukraine and the Middle East and their impact on UK and
European energy markets. When added to the impact of the evolving
UK Government response to climate change and changes to the
regulatory environment, I believe we have to be prepared for
volatility in energy markets and prices for the foreseeable future.
However, MED remains confident and optimistic that our business
strategy and new partner relationships will enable the Group to
deliver positive results from a growing robust projects portfolio
over the course of the next 12 months and beyond.
In conclusion I would like to
thank Pieter Krügel and his management team for their ongoing
execution of the MED business strategy which has seen significant
positive progress during 2024 following the challenging events the
Company faced during 2023, and I look forward to supporting them as
we build towards our target of 300+ MWs of flexible power
generation available to the UK energy market.
This report was approved on 29
April 2025 by:
Paul Venter
Non-Executive Chairman
Financial summary of the MAST Energy Developments PLC
Group
The following information is
included to highlight the financial performance of the Group in its
inaugural period of operations.
Description
|
|
Year ended
31 December
2024
|
Year ended
31 December
2023
|
Revenue
|
|
737,158
|
341,207
|
Cost of sales
|
|
(441,541)
|
(223,838)
|
Gross profit
|
|
295,617
|
117,369
|
Administrative expenses
|
|
(764,441)
|
(941,941)
|
Listing and capital raising
fees
|
|
(130,421)
|
(464,853)
|
Project expenditure
|
|
(340,582)
|
(343,718)
|
Impairment
|
|
-
|
(1,857,604)
|
Disposal/de-recognition of
non-current asset
|
|
87,005
|
-
|
Other
income
|
|
-
|
40,375
|
Finance income
|
|
18
|
1,117
|
Finance costs
|
|
(244,629)
|
(90,139)
|
Loss for the
period
|
|
(1,097,433)
|
(3,539,394)
|
The decrease in the loss
year-on-year, as disclosed in the table above and in the statement
of comprehensive income, is mainly owing to the following
reasons:
•
Revenue increased 77% year-on-year due the
comprehensive refurbishment programme started at Pyebridge earlier
in 2024 in partnership with RiverFort and the successful completion
of the overhaul of two engines at the Pyebridge site. The first
overhauled engine was commissioned in July 2024, and the second
during December 2024. The increase in cost of sales is directly
aligned with the increase in revenue.
•
Pyebridge successfully qualified for and secured
a number of Capacity Market ("CM") contracts, the first being a T-1
CM contract for delivery year 2023/2024 and the second CM for the
delivery year 2024/2025, contributing to increased revenue earnings
compared to 2023.
•
Administrative expenses reduced with 19%
year-on-year, due to concerted efforts to reduce costs.
•
Listing and capital raising fees reduced with 72%
year-on-year since new shares were only issued on one occasion
during 2024.
•
The impairment expense in 2023 was high due the
pressure on the UK economy which influenced the assumptions used by
management for the impairment assessment. There were no impairments
recognised in 2024 largely due to the current improved market
conditions, most notably the inflation and interest rate
environment that have stabilised since 2023. Possible impairment
reversals were identified during the impairment assessment
performed as at year-end, but are not recognised in the accounts
until it is confirmed to be of more permanent nature. Refer to note
11 for further details.
•
A gain on disposal of the Rochdale site to the
value of c. £16k.
•
The de-recognition of the Stather Road lease (c.
£70k) that was due to a Deed of Variation signed during 2024
resulting in the lease liability and corresponding right-of-use
asset being de-recognised in terms of IFRS16. Due to the asset
being impaired in 2023, it is showing as a gain in 2024.
There have been no dividends
declared or paid during the current financial period (2023: £
Nil).
REPONSIBILITY STATEMENT
We confirm to the best of our
knowledge:
a)
the condensed set of financial statements has
been prepared in accordance with IAS 34 'Interim
Financial Reporting';
b) the Directors'
Statement includes a fair review of the information required by the
Disclosure and Transparency Rule DTR 4.2.7R (indication of
important events during the year); and
c) the
Directors' Statement includes a fair review of the information
required by the Disclosure and Transparency Rule DTR 4.2.8R
(disclosure of related party transactions and changes therein);
and
d) this report
contains certain forward-looking statements with respect to the
operations, performance, and financial condition of the Group. By
their nature, these statements involve uncertainty since future
events and circumstances can cause results and developments to
differ materially from those anticipated.
The forward-looking statements
reflect knowledge and information available at the date of
preparation of this financial report and the Company undertakes no
obligation to update these forward-looking statements.
Nothing in this financial report
should be construed as a profit forecast.
CONDENSED CONSOLIDATED
STATEMENT OF COMPREHENSIVE INCOME
|
|
Group
|
|
|
Year ended
31 December
2024
|
Year ended
31 December
2023
|
|
|
Audited
|
Audited
|
|
Note
|
£
|
£
|
|
|
|
|
Revenue
|
|
737,158
|
341,207
|
Cost of sales
|
|
(441,541)
|
(223,838)
|
Gross profit/(loss)
|
|
295,617
|
117,369
|
Administrative expenses
|
|
(764,441)
|
(941,941)
|
Listing and other corporate
fees
|
|
(130,421)
|
(464,853)
|
Project expenditure
|
|
(340,582)
|
(343,718)
|
Impairment
|
7&8
|
-
|
(1,857,604)
|
Operating loss
|
|
(939,827)
|
(3,490,747)
|
Other income
|
|
87,005
|
40,375
|
Finance income
|
|
18
|
1,117
|
Finance costs
|
|
(244,629)
|
(90,139)
|
Loss before tax
|
|
(1,097,433)
|
(3,539,394)
|
Taxation
|
|
|
-
|
Loss for the
period
|
|
(1,097,433)
|
(3,539,394)
|
Total comprehensive loss for the
period
|
|
(1,097,433)
|
(3,539,394)
|
|
|
|
|
Loss for the period
|
|
(1,097,433)
|
(3,539,394)
|
Attributable to the owners of the
parent
|
|
(1,097,433)
|
(3,539,394)
|
Attributable to the non-controlling
interest
|
|
-
|
-
|
|
|
|
|
Total comprehensive loss for the period
|
|
(1,097,433)
|
(3,539,394)
|
Attributable to the owners of the
parent
|
|
(1,097,433)
|
(3,539,394)
|
|
|
-
|
|
Loss Per Share
|
|
|
|
Basic loss per
share(pence)
|
6
|
(0.32)
|
(1.51)
|
Diluted loss per
share(pence)
|
6
|
(0.32)
|
(1.51)
|
|
|
|
|
|
|
|
|
CONDENSED CONSOLIDATED
STATEMENT OF FINANCIAL POSITION AS AT 31 DECEMBER
2024
|
|
Group
|
|
|
31 December
2024
|
31 December
2023
|
|
|
Audited
|
Audited
|
|
Note
|
£
|
£
|
Assets
|
|
|
|
Non‑Current Assets
|
|
|
|
Property, plant and
equipment
|
7
|
3,278,530
|
2,080,869
|
Intangible assets
|
8
|
247,405
|
397,779
|
Total non-current assets
|
|
3,525,935
|
2,478,648
|
|
|
|
|
Current Assets
|
|
|
|
Other receivables
|
|
364,469
|
122,649
|
Cash and cash
equivalents
|
|
146,446
|
252
|
Total current assets
|
|
510,915
|
122,901
|
|
|
|
|
Total Assets
|
|
4,036,850
|
2,601,549
|
|
|
|
|
Equity and Liabilities
|
|
|
|
Equity
|
|
|
|
Called up share capital
|
10
|
426,354
|
263,854
|
Share premium account
|
10
|
13,326,277
|
13,183,277
|
Share reserve
|
|
-
|
81,329
|
Warrant reserve
|
12
|
400,241
|
380,741
|
Common control reserve
|
11
|
383,048
|
383,048
|
Non-controlling interest
acquired
|
11
|
(4,065,586)
|
(4,065,586)
|
Retained deficit
|
|
(11708,605)
|
(10,611,172)
|
Total Equity
|
|
(1,238,271)
|
(384,509)
|
|
|
|
|
Liabilities
|
|
|
|
Non-current
Liabilities
|
|
|
|
Lease liability
|
7
|
341,149
|
405,390
|
Other financial
liabilities
|
14
|
2,268,089
|
318,925
|
Total non-current
liabilities
|
|
2,609,238
|
724,315
|
|
|
|
|
Current
Liabilities
|
|
|
|
Loans from related
parties
|
13
|
-
|
849,253
|
Trade and other
payables
|
|
696,049
|
941,688
|
Other financial
liabilities
|
14
|
1,965,967
|
444,365
|
Lease liability
|
7
|
3,867
|
4,205
|
CLN Derivative
liability
|
14
|
-
|
22,232
|
Total current liabilities
|
|
2,665,883
|
2,261,743
|
Total Liabilities
|
|
5,275,121
|
2,986,058
|
|
|
|
|
Total Equity and Liabilities
|
|
4,036,850
|
2,601,549
|
|
|
|
|
CONDENSED CONSOLIDATED
STATEMENTS OF CHANGES IN EQUITY
|
Share
Capital
|
Share
Premium
|
Share
Reserve
|
Common Control
Reserve
|
Warrant
Reserve
|
Non-controlling interest
acquired
|
Retained
deficit
|
Total
|
|
£
|
£
|
£
|
£
|
£
|
£
|
£
|
£
|
Balance at 31 December 2022
|
217,453
|
12,653,607
|
-
|
383,048
|
-
|
(4,065,586)
|
(7,071,778)
|
2,116,744
|
Total comprehensive loss for the
period
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,539,394)
|
(3,539,394)
|
Warrants issued during the
year
|
-
|
-
|
-
|
-
|
380,741
|
-
|
-
|
380,741
|
Loans partially settled in
shares
|
14,755
|
92,317
|
-
|
-
|
-
|
-
|
-
|
107,072
|
Director's loan repayable in
shares
|
-
|
-
|
81.329
|
-
|
-
|
-
|
-
|
81,329
|
Loan with holding company settled in
shares
|
31,646
|
437,353
|
-
|
-
|
-
|
-
|
-
|
468,999
|
Balance at 31 December 2023
|
263,854
|
13,183,277
|
81,329
|
383,048
|
380,741
|
(4,065,586)
|
(10,611,172)
|
(384,509)
|
Total comprehensive loss for the
period
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,097,4330)
|
(1,097,433)
|
Shares issued
|
162,500
|
143,000
|
-
|
-
|
19,500
|
-
|
-
|
325,000
|
Derecognition of equity component
of director's loan repayable in shares
|
-
|
-
|
(81,329)
|
-
|
-
|
-
|
-
|
(81,329)
|
Balance at 31 December 2024
|
426,354
|
13,326,277
|
-
|
383,048
|
400,241
|
(4,065,586)
|
(11,708,605)
|
(1,238,271)
|
CONDENSED CONSOLIDATED
STATEMENT OF CASH FLOW
|
|
|
|
|
Group
|
|
|
Year ended
31 December
2024
|
Year ended
31
December
2023
|
|
|
|
Audited
|
Audited
|
|
|
Note
|
£
|
£
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
|
|
|
Loss for the period before taxation
|
|
(1,097,433)
|
(3,539,394)
|
|
|
|
|
|
|
Adjustments for non-cash items:
|
|
|
|
|
Depreciation
|
7
|
78,894
|
74,542
|
|
Impairment of intangible
assets
|
8
|
-
|
1,397,904
|
|
Impairment of PPE
|
|
-
|
459,700
|
|
Gains on disposal of non-current
assets
|
|
(87,005)
|
|
|
Implementation fee on reprofiling of
convertible loan notes
|
|
-
|
48,950
|
|
Loss/(gain) on revaluation of CLN
derivative liabilities
|
|
-
|
86,558
|
|
Non-cash interest accrued
|
|
244,629
|
88,731
|
|
Amounts due settled from share issue
proceeds
|
|
64,500
|
-
|
|
Amounts due settled from Rochdale
disposal proceeds
|
|
41,234
|
-
|
|
Other non-cash items
|
|
11,451
|
369
|
|
|
|
(743,730)
|
(1,382,640)
|
|
Movement in working capital
|
|
|
|
|
Decrease/(increase) in
debtors
|
|
(241,820)
|
14,152
|
|
Increase in creditors
|
|
(245,639)
|
641,363
|
|
|
|
(487,459)
|
655,515
|
|
Net cash outflows from operating
activities
|
|
(1,231,189)
|
(727,125)
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
Disposal of subsidiary
|
|
216,936
|
-
|
|
Property, plant and equipment
acquired
|
|
(1,636,555)
|
-
|
|
Property, plant and equipment
disposed
|
|
270,000
|
-
|
|
Net
cash outflows from investing activities
|
|
(1,149,619)
|
-
|
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
Lease liability repaid
|
7
|
(39,826)
|
(39,292)
|
|
Loans from related parties
repaid
|
13
|
|
-
|
|
Proceeds from convertible loan
notes
|
14
|
-
|
85,800
|
|
Proceeds from term loan
|
|
2,839,297
|
-
|
|
Repayment of term loan
|
|
(529,969)
|
-
|
|
Repayments of director's
loan
|
|
(3,000)
|
-
|
|
Shares issued net of share issue
costs
|
|
260,500
|
-
|
|
Proceeds from director's
loan
|
|
-
|
81,329
|
|
Proceeds from shareholder's
loan
|
|
-
|
86,615
|
|
Warrants issued
|
|
-
|
380,741
|
|
Net
cash flows financing activities
|
|
2,527,002
|
595,193
|
|
|
|
|
|
|
Net
(decrease) / increase in cash and cash
equivalents
|
|
146,194
|
(131,932)
|
|
Cash and cash equivalents at
beginning of period
|
|
252
|
132,184
|
|
Cash and cash equivalents at end of
the period
|
|
146,446
|
252
|
|
NOTES TO THE UNAUDITED
CONDENSED CONSOLIDATED ANNUAL FINANCIAL
STATEMENTS
FOR THE YEAR ENDED 31
DECEMBER 2023
Note 1: General information
MAST Energy Developments PLC
('MAST' or 'MED' or the 'Company') is
incorporated in England & Wales as a public limited
company. The Company's registered office
is located at 55 Ludgate Hill, London, United Kingdom, EC4M
7JW.
The principal activity of MAST,
through its subsidiaries (together the 'Group'), is to acquire and
develop a portfolio of flexible power plants in the UK and become a
multi-asset operator in the rapidly growing Reserve Power
market.
Note 2: Statement of Preparation
The Group and Company's financial
statements have been prepared in accordance with international
accounting standards in conformity with the requirements of the
Companies Act 2006 and international financial reporting standards
adopted by the United Kingdom. The individual financial statements
of the Company ("Company financial statements") have been prepared
in accordance with the Companies Act 2006 and UK adopted
international financial reporting standards.
Note 3: Consolidation
The consolidated annual financial
statements comprise the financial statements of MAST Energy
Developments PLC and its subsidiaries for the year ended 31
December 2024, over which the Company has control.
Control is achieved when the
Company:
·
has the power over the investee;
·
is exposed, or has rights, to variable return
from its involvement with the investee; and
·
has the ability to use its power to affect its
returns.
In assessing control, potential
voting rights that are currently exercisable or convertible are
taken into account. Subsidiaries are fully consolidated from the
date that control commences until the date that control ceases.
Accounting policies of subsidiaries have been changed where
necessary to ensure consistency with the policies adopted by the
Group. Intragroup balances and any unrealised gains or losses or
income or expenses arising from intragroup transactions are
eliminated in preparing the Group financial statements, except to
the extent they provide evidence of impairment.
The Group accounts for business
combinations using the acquisition method of accounting. The cost
of the business combination is measured as the aggregate of the
fair values of assets given, liabilities incurred or assumed and
equity instruments issued. Costs directly attributable to the
business combination are expensed as incurred, except the costs to
issue debt which are amortised as part of the effective interest
and costs to issue equity which are included in equity.
The acquiree's identifiable
assets, liabilities and contingent liabilities which meet the
recognition conditions of IFRS 3 Business Combinations are
recognised at their fair values at acquisition date.
Contingent liabilities are only
included in the identifiable assets and liabilities of the acquiree
where there is a present obligation at acquisition date.
Non-controlling interest arising
from a business combination is measured either at their share of
the net asset value of the assets and liabilities of the acquiree
or at fair value. The treatment is not an accounting policy choice
but is selected for each individual business combination, and
disclosed in the note for business combinations.
Changes in the Group's interest in
subsidiaries that do not result in a loss of control are accounted
for as equity transactions.
Note 4: Going
concern
The financial results have been
prepared on the going concern basis that contemplates the
continuity of normal business activities, the realisation of assets
and the settlement of liabilities in the normal course of
business.
The financial results have been
prepared on the going concern basis that contemplates the
continuity of normal business activities, the realisation of assets
and the settlement of liabilities in the normal course of
business.
In performing the going concern
assessment, the Board considered various factors, including the
availability of cash and cash equivalents, data relating to working
capital requirements for the foreseeable future, cashflows from
operational activities, available information about the future, the
possible outcomes of planned events, changes in future conditions,
geopolitical events (e.g. escalation of the Ukraine conflict), and
the responses to such events and conditions that would be available
to the Board.
The Board has, inter alia,
considered the following specific factors in determining whether
the Group is a going concern:
·
The total comprehensive loss for the year of
£1,097,433 compared to £3,539,394 for the preceding 12
month-financial period;
·
Cash and cash equivalents available to the Group
in the amount of £146,446 in order to partially pay its creditors
and maturing liabilities (excluding the Pyebridge facilities) in
the amount of £2,558,320; and
·
MED and Pyebridge has a secured funding facility
of up to GBP 4 million from RiverFort, of which the Company has
drawn £2,769,297. The main focus of the facility is to overhaul the
Pyebridge gensets in order to get the site generating at its full
efficiency and income potential. The current outstanding balance is
£2,131,328 following repayments totalling £637,969.
·
Whether the Group has available cash resources,
or equivalent short term funding opportunities in the foreseeable
future, to deploy in developing and growing existing operations or
invest in new opportunities.
· Post
reporting period end, on 20 March 2025, the Company announced it
has signed a binding definitive investment agreement (the
"Investment Agreement") with Powertree (Holdings)
Ltd ("Powertree"). Under the Investment
Agreement, Powertree will invest up
to £5,000,000 into MED's Hindlip project (the "Investment
Consideration"), resulting in the Hindlip project being fully
funded.
The Directors have evaluated the
Group's liquidity requirements to confirm the Group has adequate
cash resources to continue as a going concern for the foreseeable
future. Considering the net current liability position, the
Directors have reviewed financial projections to 30 August 2026
which include estimates and assumptions regarding the future
revenues and costs and timing of these. The financial projection
includes non-committed capex expenditure for the overhaul of the
third Pyebridge engine. Thereby projecting revenue for up to three
revenue producing Pyebridge engines during 2025. It includes the
signed capacity market contracts income.
Based on the cash flow forecast
the group experiences cash shortfall throughout the forecast
period, ending with a shortfall of c. £286,000 at the end of Aug
2026. The cashflow forecast is reliant on a successful drawdown on
a current facility, as well as successful electricity generation by
Pyebridge. Unforeseen challenges with either of the aforementioned
cause a risk that the Company may not be able to meet its current
liabilities without another cash injection. In the event that
further funding cannot be secured, the Group may experience
continuous cash shortfalls over the next 18 months. The directors
are in negotiations with funders and lenders to upgrade and/or
develop the sites as per the business model of the
Company.
In response to the net current
liability position and to address future cashflow requirements,
detailed liquidity improvement initiatives have been identified and
are being pursued, with their implementation regularly monitored in
order to ensure the Group is able to alleviate the liquidity
constraints in the foreseeable future. Cost saving measures were
identified and implemented on operational expenditure.
The Group has identified the below
options in order to address the liquidity risk the Group faces on
an ongoing basis. The ability of the Group to continue as a going
concern is dependent on the successful implementation or conclusion
of one or more of the below:
·
The successful drawdown on the funding facility
of £4,000,000 with RiverFort. There are terms and conditions
limiting the drawdown which has to be adhered to.
·
Raising of short- and medium term working capital
and project capex funding, by way of capital placings.
·
Successful conclusion of current funding
opportunities of the Group with strategic funders regarding the
funding of specific projects and/or the business.
·
Obtaining debt funding or other funding
instruments such as credit loan notes to fund MED
projects.
·
Successful cash generation from the Pyebridge
power-generation facilities in order to achieve net-cash positive
contributions toward the larger Group.
Although there is no guarantee,
the Directors have a reasonable expectation that the Group will be
able to raise further financing to support its ongoing development
and commercialisation activities and continue in operational
existence for the next 12 months, from date of sign off of these
financial statements. The directors have concluded that the
combination of these circumstances represents a material
uncertainty that casts significant doubt upon the Group's ability
to continue as a going concern and that, therefore, the Group may
be unable to realise its assets and discharge its liabilities in
the normal course of business. As the Board is confident it would
be able to successfully implement the above responses, it has
adopted the going concern basis of accounting in preparing the
consolidated financial statements.
Note 5: Segmental Reporting
The Group discloses segmental
analysis based on its different operations, being Bordersley,
Rochdale . ADV 001 (Hindlip Lane), ARL 018 (Stather Road) and
Pyebridge
31
December 2024
|
ADV001 Hindlip
Lane
|
ARL018 Stather
Road
|
Bordersley
|
Rochdale
|
Pyebridge
|
Treasury and
Investment
|
Group
|
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
Revenue
|
-
|
-
|
-
|
-
|
737,158
|
-
|
737,158
|
Cost of sales
|
-
|
-
|
-
|
-
|
(441,541)
|
-
|
(441,541)
|
Administrative and other
expenses
|
(36,470)
|
(9,820)
|
(9,248)
|
(2,616)
|
(73,218)
|
(763,490)
|
(894,862)
|
Depreciation
|
-
|
-
|
-
|
-
|
(77,305)
|
(1,589)
|
(78,894)
|
Project costs
|
(2,278)
|
(512)
|
(6,717)
|
(1,171)
|
(299,424)
|
48,414
|
(261,688)
|
Other income
|
-
|
70,673
|
|
|
|
16,350
|
87,023
|
Finance costs
|
(230)
|
(3,690)
|
(29,309)
|
-
|
(136,329)
|
(75,071)
|
(244,629)
|
Operating profit/(loss)
|
(38,978)
|
56,651
|
(45,274)
|
(3,787)
|
(290,659)
|
(775,386)
|
(1,097,433)
|
|
|
|
|
|
|
|
|
Total assets
|
110,597
|
5,248
|
50,749
|
-
|
3,591,046
|
279,210
|
4,036,850
|
Capital expenditure
|
-
|
-
|
-
|
-
|
1,636,555
|
-
|
1,636,555
|
Total liabilities
|
(128,077)
|
(59,657)
|
(398,656)
|
-
|
(2,595,350)
|
(2,093,381)
|
(5,275,121)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31
December 2023
|
ADV001 Hindlip
Lane
|
ARL018 Stather
Road
|
Bordersley
|
Rochdale
|
Pyebridge
|
Treasury and
Investment
|
Group
|
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
Revenue
|
-
|
-
|
-
|
-
|
341,207
|
-
|
341,207
|
Cost of sales
|
-
|
-
|
-
|
-
|
(223,838)
|
-
|
(223,838)
|
Administration and other
expenses
|
(14,032)
|
(20,313)
|
(37,736)
|
(9,377)
|
(46,424)
|
(1,319,017)
|
(1,447,169)
|
Impairment
|
-
|
(208,398)
|
(1,649,206)
|
-
|
-
|
-
|
(1,857,604)
|
Project costs
|
(38,434)
|
(5,743)
|
(27,972)
|
(23,396)
|
(173,631)
|
-
|
(296,176)
|
Other income
|
-
|
-
|
-
|
-
|
126,933
|
(86,558)
|
40,375
|
Depreciation
|
-
|
(2,509)
|
(11,941)
|
-
|
(58,504)
|
(1,589)
|
(74,542)
|
Operating loss
|
(52,736)
|
(236,963)
|
(1,726,855)
|
(32,773)
|
(34,257)
|
(1,407,163)
|
(3,490,747)
|
|
|
|
|
|
|
|
|
Total assets
|
9,163
|
117,215
|
392,155
|
91,134
|
2,020,584
|
28,702
|
2,658,953
|
Total liabilities
|
(25,979)
|
(139,276)
|
(389,225)
|
(38,391)
|
(174,537)
|
(2,218,650)
|
(2,986,058)
|
As the Group currently operates
solely from the United Kingdom, consequently there is no segmented
disclosure with regard to different geographic areas of
operation.
Note 6: Loss per share
Basic loss per share
The basic loss and weighted
average number of ordinary shares used for calculation purposes
comprise the following:
Basic loss per share
|
|
31 December 2024
(£)
|
31 December 2023
(£)
|
Loss for the period attributable
to equity holders of the parent
|
|
(1,097,433)
|
(3,539,394)
|
|
|
|
|
Weighted average number of
ordinary shares for the purposes of basic loss per share
|
|
340,131,101
|
234,172,196
|
|
|
|
|
Basic loss per ordinary share
(pence)
|
|
(0.32)
|
(1.51)
|
The Group has no dilutive
instruments in issue as at year end.
Note 7: Property, plant and equipment
Group
|
Land
|
Plant &
Machinery
|
Right of use
assets
|
Computer
Equipment
|
Asset under
construction
|
Total
|
Cost
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
Opening Cost as at 1 January 2024
|
602,500
|
1,538,629
|
418,157
|
4,766
|
126,800
|
2,690,852
|
Derecognition of leases
|
-
|
-
|
(62,717)
|
-
|
-
|
(62,717)
|
Additions
|
-
|
1,604,340
|
-
|
-
|
32,215
|
1,636,555
|
Disposals
|
(90,000)
|
(270,000)
|
-
|
-
|
-
|
(360,000)
|
Closing Cost as at 31 December 2024
|
512,500
|
2,872,969
|
355,440
|
4,766
|
159,015
|
3,904,690
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Depreciation ("Acc Depr")
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
Opening Acc Depr as at 1 January 2024
|
-
|
(111,136)
|
(418,157)
|
(2,340)
|
(78,350)
|
(609,983)
|
Depreciation
|
-
|
(77,306)
|
-
|
(1,588)
|
-
|
(78,894)
|
Derecognition of leases
|
-
|
-
|
62,717
|
-
|
-
|
62,717
|
Acc
Depr as at 31 December 2024
|
-
|
(188,442)
|
(355,440)
|
(3,928)
|
(78,350)
|
(626,160)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Value
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
(£)
|
Carrying value as at 31 December 2023
|
602,500
|
1,427,493
|
-
|
2,426
|
48,450
|
2,080,869
|
Carrying value as at 31 December 2024
|
512,500
|
2,684,527
|
-
|
838
|
80,665
|
3,278,530
|
During the year, the Group
reassessed its property, plant and equipment's value in use and
found that the conditions that previously lead to its impairment
have improved. This has led to reversal of impairments.
Right of use asset
|
31 December
2024(£)
Group
|
31 December
2023(£)
Group
|
Set out below are the carrying amounts of right-of-use assets
recognised and the movements during the period:
|
|
|
Opening balance
|
-
|
333,525
|
Change in lease
|
-
|
62,274
|
Impairment
|
-
|
(381,350)
|
Depreciation
|
-
|
(14,449)
|
Closing balance
|
-
|
-
|
|
|
|
Lease liability
|
|
|
Set out below are the carrying amounts of lease liabilities
and the movements during the period:
|
|
|
Opening balance
|
409,595
|
350,654
|
Interest
|
35,621
|
35,959
|
Change in lease
|
(60,373)
|
62,274
|
Repayment
|
(39,826)
|
(39,292)
|
Closing balance
|
345,016
|
409,595
|
|
|
|
Split of lease liability between current and non-current
portions:
|
|
|
Non-current
|
341,149
|
405,930
|
Current
|
3,867
|
4,205
|
Total
|
345,016
|
405,595
|
Future minimum lease payments fall due as
follows
|
|
|
- within 1 year
|
32,866
|
39,826
|
- later than 1 year but within 5
years
|
159,304
|
159,304
|
- later than 5 years
|
690,186
|
851,812
|
Subtotal
|
854,516
|
1,050,942
|
- Unearned future finance
charges
|
(537,340)
|
(641,347)
|
Closing balance
|
345,016
|
409,595
|
The Group has two lease contracts
for land it shall utilise to construct gas-fuelled power generation
plants. The land is located at Bordesley, Liverpool St. Birmingham
and Stather Road, Flixborough. The Stather
Road lease has been derecognised following deed of variations
entered into with the lessors delaying the inception date of the
lease until such time that the conditions linked to the inception
date are met. There is no clear indication of the date in which the
conditions will be met.
The lease of the land has a lease
term of 20 years, with an option to extend for 10 years which the
Group has opted to include due to the highly likely nature of
extension as at the time of the original assessment.
The Group's obligations under its
leases are secured by the lessor's title to the leased assets. The
Group's incremental borrowing is 10.38%.
Note 8: Intangible assets
Intangible assets consist of
separately identifiable assets, property rights or intellectual
property (Bordersley Power) acquired either through business
combinations or through separate asset acquisitions. These
intangible assets are recognised at the respective fair values of
the underlying asset acquired, or where the fair value of the
underlying asset acquired is not readily available, the fair value
of the consideration.
The following reconciliation
serves to summarise the composition of intangible assets as at
period end:
Group
|
Rochdale Power
(£)
|
Bordersley Power
(£)
|
ARL018 Stather Road
(£)
|
ADV001 Hindlip Lane
(£)
|
Total
(£)
|
Carrying value as at 1 January 2023
|
150,273
|
1,306,422
|
91,482
|
247,506
|
1,795,683
|
Impairments
|
-
|
(1,306,422)
|
(91,482)
|
-
|
(1,397,904)
|
Carrying value as at 31 December 2023
|
150,273
|
-
|
-
|
247,506
|
397,779
|
Disposal of Rochdale
Power
|
(150,273)
|
-
|
-
|
-
|
(150,273)
|
Modification
|
-
|
-
|
-
|
(101)
|
(101)
|
Carrying value as at 31 December 2024
|
-
|
-
|
-
|
247,405
|
247,405
|
Note 9: Acquisition of interests in other
entities
Sloane Energy Limited - 2023
During 2023, Sloane Developments
(Sloane) founded and acquired 100% equity interest in Sloane Energy
Limited. At the reporting date the company was dormant.
Rochdale Power Limited - 2024
During 2024, Sloane disposed of
its interest in Rochdale Power Limited for an amount of £258,170.
The proceeds were applied against amounts due by Rochdale with the
remainder of £216,936 paid to the Group. The net asset value of the
project assets and liabilities at disposal date was £200,603. The
group recognised a profit on disposal of £16,333.
Note 10: Share Capital
The called-up and fully paid share
capital of the Company is as follows:
|
2024
|
2023
|
Allotted, issued and fully paid shares
|
|
|
(2024: 426,354,067 Ordinary shares
of £0.001 each)
|
£426,354
|
-
|
(2023: 263,854,067 Ordinary shares
of £0.001 each)
|
-
|
£263,854
|
|
|
£426,354
|
£263,854
|
|
|
|
|
|
Number of
Shares
|
Ordinary Share Capital
(£)
|
Share Premium
(£)
|
Balance at 31 December 2023
|
263,854,067
|
263,854
|
13,183,277
|
Issue of shares
|
162,500,000
|
162,500
|
143,000
|
Balance at 31 December 2024
|
426,354,067
|
426,354
|
13,326,277
|
|
|
|
|
| |
All ordinary shares issued have
the right to vote, right to receive dividends, a copy of the annual
report, and the right to transfer ownership of their
shares.
The group and company issued the
following ordinary shares during the period, with regard to key
transactions:
• 162,500,000 new MED Shares of
£0.001 each were issued on 7 May 2024 at a deemed issue price of
£0.002 for £325,000 of which £64,500 was applied against share
issue costs and accrued brokers fees.
Note 11: Reserves
Common control reserve
The common control reserve is the
result of the capital reorganisation between the company, its
holding and ultimate holding company during the 2020 financial
year. As the reorganisation was outside the scope of IFRS 3,
predecessor valuation accounting was applied as a result of the
common control transaction. The common control reserve amounts to
£383,048 (2023: £383,048).
Non-controlling interest acquired
On 31 July 2020, Sloane
Developments Limited, MAST Energy Projects Limited and St. Anderton
on Vaal Limited entered into the Share Exchange Agreement relating
to the acquisition by Sloane Developments Limited of the remaining
40% of the issued share capital of MAST Energy Projects Limited.
Under the Share Exchange Agreement, the Company paid St Anderton on
Vaal Limited the sum of £4,065,586 payable by the issue of
36,917,076 ordinary shares of £0.001 each in the Company.
Completion of the Share Exchange Agreement was subject to and
conditional upon the Admission of Mast Energy Developments Limited
to the London Stock Exchange.
Following the completion of the
IPO on 14 April 2021, the Group acquired the remaining equity
interest in MAST Energy Projects Ltd for the consideration equal to
36,917,076 shares at a total value of £4,065,586. As the
controlling stake in the entity had already been acquired and was
under control of MED, the transaction was seen as a transaction
with owners, and the financial impact recognised directly in equity
of £4,065,586.
The rationale for the transaction
was to acquire the remaining equity within MAST Energy Projects
Limited in order to have the exclusive see-through equity interest
in the Bordersley project, held in the form of royalty and revenue
agreements between MAST Energy Projects Limited and Bordersley
Power Limited, from which MED could restructure the Group through
its SPV's.
Note 12: Warrants
The following reconciliation serves
to summarise the value attributable to the warrant reserve as at
period end for the Company:
|
|
Group and
Company (£)
|
|
|
2024
|
2023
|
Opening balance of warrant
reserve
|
|
380,741
|
-
|
Issue of warrants
|
|
19,500
|
380,741
|
|
|
400,241
|
380,741
|
The following reconciliation serves
to summarise the quantity of warrants in issue as at period
end:
|
|
Group and
Company (£)
(number of
warrants)
|
|
|
2024
|
2023
|
Opening balance
|
|
86,814,562
|
-
|
New warrants issued
|
|
9,750,000
|
86,814,562
|
|
|
96,564,562
|
86,814,562
|
The weighted average fair value of
the warrants is 0.41p per warrant (2023: £0.44p)
At 31 December 2024 the Group had
96,564,562 warrants outstanding:
Warrants
|
Date of
Grant
|
Issue date
|
Expiry
date
|
Exercise
price
|
Number
granted
|
Exercisable as at 31
December 2024
|
|
18 May 2023
|
18 May 2023
|
18 May 2026
|
2p
|
2,255,656
|
2,255,656
|
|
18 May 2023
|
18 May 2023
|
18 May 2026
|
2p
|
2,255,656
|
2,255,656
|
|
18 May 2023
|
18 May 2023
|
18 May 2027
|
0.89p
|
20,575,813
|
20,575,813
|
|
18 May 2023
|
18 May 2023
|
18 May 2027
|
1.8p
|
20,575,813
|
20,575,813
|
|
18 May 2023
|
18 May 2023
|
18 May 2027
|
0.89p
|
20,575,812
|
20,575,812
|
|
18 May 2023
|
18 May 2023
|
18 May 2027
|
1.8p
|
20,575,812
|
20,575,812
|
|
29 May 2024
|
29 May 2024
|
29 May 2027
|
0.2p
|
9,750,000
|
9,750,000
|
|
|
|
|
|
96,564,562
|
96,564,562
|
|
|
|
|
|
|
|
|
Total contingently issuable shares
|
96,564,562
|
96,564,562
|
Note 13: Loan from related parties
|
Group 2024
(£)
|
Group 2023
(£)
|
Company 2024
(£)
|
Company 2023
(£)
|
Amounts falling due within one year:
|
|
|
|
|
Kibo Mining (Cyprus)
Limited
|
-
|
849,253
|
-
|
-
|
Pyebridge Power Limited
|
-
|
-
|
375,047
|
-
|
|
-
|
849,253
|
375,047
|
-
|
The loan is unsecured, carries
interest at 0%, and is repayable on demand. The carrying value of
loans from related parties equals their fair value due mainly to
the short-term nature of the liability.
Note 14: Other financial and derivative
liabilities
Description
|
Liable group
company
|
Group
2024(£)
|
Group
2023(£)
|
Company 2024
(£)
|
Company 2023
(£)
|
|
|
|
|
|
|
Amounts falling due within one year:
|
|
|
|
|
|
Convertible loan notes
|
MED
|
854,594
|
444,100
|
854,594
|
444,100
|
CLN Derivative
liability
|
MED
|
-
|
22,232
|
-
|
22,232
|
Loan - RiverFort
|
Sloane
Developments
|
849,253
|
-
|
-
|
-
|
Term loan - Powertree
|
Hindlip
|
70,230
|
-
|
-
|
-
|
Term loan - RiverFort
|
Pyebridge
|
107,563
|
-
|
-
|
-
|
Accrued interest on director's
loan
|
MED
|
5,998
|
265
|
5,998
|
265
|
Director's loan
|
MED
|
78,329
|
-
|
78,329
|
-
|
|
|
1,965,967
|
466,597
|
938,921
|
466,597
|
|
|
|
|
|
|
Amounts falling due between one year and five
years:
|
|
|
|
|
|
Convertible loan notes
|
MED
|
-
|
318,925
|
-
|
318,925
|
Term loan - RiverFort
|
Pyebridge
|
2,268,089
|
-
|
-
|
-
|
|
|
2,268,089
|
785,522
|
-
|
785,522
|
|
|
4,234,056
|
785,522
|
938,921
|
785,522
|
Convertible loan notes
Convertible loan notes consist of
a facility from institutional lenders which reprofiled the
outstanding convertible loan notes held during the previous
financial year. The interest accrues at 9.5% to 10% per annum based
on the terms applied for each advance of the facility. The
convertible loan notes have embedded derivative liabilities which
were recognised at fair value.
Term loans
The term loans are from
institutional lenders. The interest accrues at 10% to 12% per
annum.
· The
"Term loan - Powertree" is payable by the Hindlip project SPV. The
loan was used to pay the Capacity Market deposit. This loan is
payable in full during the 2025 financial year and bears interest
at 10% per annum. The term loan has been rolled up into the
investment agreement after year-end. Refer to note 16.
· The
"Term loan - RiverFort" is payable by the Pyebridge SPV. The
funding was used to overhaul the two engines at the Pyebridge site.
The loan consists of three separate drawdowns all repayable during
the 2026 financial year and bear interest at 12% per
annum.
· The
"Loan - Riverfort" is the historic shareholder loan owing by the
Company to its former parent company, Kibo Energy PLC ("Kibo"),
which Kibo sold to RiverFort during 2024. This loan has no fixed
repayment terms and is repayable on demand and bears no
interest.
Accrued interest on director's loan
The director's loan consists of
interest payable on a director's loan which is to be settled in
cash. The interest is accrued at 7% per annum.
Note 15: Related Parties
Related parties of the Group
comprise subsidiaries, significant shareholders and the
Directors.
Relationships
Board of Directors/ Key Management
Name
|
Relationship (Directors of:)
|
Paul Venter
|
PSCD Power 1 Ltd
|
Louis Coetzee
|
Kibo Energy PLC and Katoro Gold
PLC (up to July 2024)
|
Dominic Traynor
|
Druces LLP (up to Nov
2024)
|
Pieter Krügel
|
Chief Executive Officer
|
Noel O'Keeffe
|
Director of subsidiaries ADV001
Ltd, ARL018 Ltd and Sloane Energy Limited
|
Other entities over which Directors/key management or their
close family have control or significant
influence:
PSCD Power 1 Ltd:
|
The Director of PSCD Power 1 Ltd
is also a Director of Mast Energy Developments PLC.
|
|
|
Kibo Mining (Cyprus)
Limited:
|
Kibo Mining (Cyprus) Limited is
the controlling shareholder of Mast Energy Developments PLC (Up to
September 2024).
|
|
|
Ultimate shareholder
|
Kibo Energy PLC (Up to September
2024).
|
|
|
Significant shareholders:
|
PSCD Power 1 Ltd
|
|
|
Associated by fellow
directorship:
|
Katoro Gold PLC (Up to June
2024)
|
|
Kibo Mining (Cyprus) Limited (Up
to July 2024)
|
|
|
MAST Energy Developments PLC is a shareholder of the
following companies and as such are considered related
parties:
Directly held
subsidiaries:
|
Sloane Developments
Limited
|
|
Bordersley Power
Limited
|
|
Pyebridge Power Limited
|
|
ADV 001 Limited
|
|
ARL 018 Limited
|
|
Sloane Energy Limited
|
Balances
Name
|
Amount
(£)
2024
|
Amount
(£)
2023
|
Kibo Mining (Cyprus) Limited - Loan
from related parties owing
|
-
|
849,253
|
Paul Venter - Director's loan owing
(share reserve)
|
-
|
81,329
|
Paul Venter - Director's loan owing
(liability)
|
78,329
|
-
|
Paul Venter - Director's loan owing
accrued interest
|
5,733
|
265
|
Kibo Energy PLC - Management and
administration services accrued
|
31,170
|
32,130
|
Katoro Gold PLC - Receivable for
management services paid on Katoro's behalf
|
4,246
|
21,140
|
Paul Venter - Director's
remuneration due
|
43,500
|
18,371
|
Louis Coetzee - Director's
remuneration due
|
47,550
|
27,000
|
Dominic Traynor- Director's
remuneration due
|
48,018
|
17,644
|
Pieter Krügel - Director's
remuneration due
|
43,844
|
49,844
|
Noel O'Keeffe -Professional services
remuneration due
|
4,500
|
9,000
|
Druces LLP - Supplier balance for
professional services
|
52,675
|
143,732
|
Transactions
Name
|
Amount
(£)
2024
|
Paul Venter - interest on
loan
|
5,733
|
Druces LLP - Professional
services
|
84,500
|
As announced in the RNS dated 7 May
2024 the Company has entered into a partial settlement deed, in
relation to the Reprofiled Balance due under the Reprofiling
Agreement. Under the terms of the settlement deed Pieter Krügel, a
director of the Company, purchased from
Riverfort £325,000 (the "Capitalised Balance") of the
Reprofiled Balance due, in consideration, Riverfort was
paid £325,000 in cash (the "Acquisition"). The
Capitalised Balance was converted into 162,500,000 new MED ordinary
shares of 0.1p (the "Subscription Shares") at a conversion price of
0.20p per share by Mr. Pieter Krügel. Following admission of the
Subscription Shares, Pieter Krügel has agreed to sell the
Subscription Shares to new investors arranged by the Company's
broker at the same price per share as the Conversion, being 0.20p
for a gross consideration of £325,000.
Transactions between the Company
and its subsidiaries, which are related parties, have been
eliminated on consolidation. The transactions during the period
between the Company and its subsidiaries included the settlement of
expenditure to/from subsidiaries, working capital funding, and
settlement of the Company's liabilities through the issue of equity
in subsidiaries. The loans from related parties do not have fixed
repayment terms and are unsecured.
Note 16: Events after reporting period
Following successful
pre-qualification for additional Capacity Market ("CM") T-1 and T-4
contracts during the assessment window in August 2024, and the
implementation of a robust CM auction bid strategy, for the first
time Pyebridge has now successfully secured both contracts at its
maximum generation capacity permissible under the CM rules. The
recent CM T-4 auction cleared at £60,000 per MW/year, and the CM
T-1 auction cleared at £20,000 per MW/year. This means that
Pyebridge now has uninterrupted CM contracts until 2029 with a
cumulative total guaranteed gross profit income value of c. £1.73m,
over and above its PPA trading income and Embedded
Benefits.
The Company has signed a binding
definitive investment agreement (the "Investment Agreement")
with Powertree (Holdings) Ltd ("Powertree"). Under the Investment
Agreement, Powertree will invest up to £5,000,000 into MED's
Hindlip project (the "Investment Consideration"), resulting in the
Hindlip project being fully funded. The Investment Consideration
will consist of £500,000 for 75% of the fully diluted ordinary
equity of the Hindlip SPV, ADV 001 Ltd and, up to £4,500,000 will
be by way of secured loan (the "Investor Loan") entered into
between Powertree (as the lender) and the Hindlip SPV (as the
borrower). MED shall retain 25% of the fully diluted ordinary
equity of the Hindlip SPV with no further funding obligations. The
closing of the Investment Agreement is subject to customary closing
conditions.
Note 17: Commitments and contingencies
The Group does not have
identifiable material commitments and contingencies as at the
reporting date.
Note 18: Principal risks
The realisation of the various
projects is dependent on the successful completion of technical
assessments, project development and project implementation and is
subject to a number of significant potential risks summarised as
follows, and described further below:
•
Funding risk;
•
Regulatory risk;
•
Commodity risk;
•
Development and construction risk;
•
Staffing and key personnel risk; and
•
Information technology risk.
•
Successful refinancing of the historic shareholder
loan amounting to £849,253 owing by the Company to its former
parent company, Kibo Energy PLC ("Kibo"), which Kibo sold to
RiverFort during 2024, resulting in the deferral of loans payable
in the foreseeable future beyond a 12-month period after sign off
of these financial statements.
Funding risk
Following the successful
conclusion of an Initial Public Offering ('IPO') on 14 April 2021,
the Group was able to raise £5.54 million in cash, which was
utilised to further advance the various projects of the Group to
date. During 2022, the Group raised a further £650 000 for
acquisitions and general working capital purposes and availed of a
further £100,000 during 2023 under the reprofiled loan with
institutional investors agreed in May 2023. During 2024, the
Company continued to avail of loan facilities under a facility
agreement with RiverFort on which £2,769,297 has been drawn down to
date, and £637,969 has been repaid.
Funds from a broker sponsored placing of £350,000
were raised and funds from a second loan facility with RiverFort on
which £350,000 was drawn down coincident with a partial
re-settlement of the same amount on the outstanding balance on the
May 2023 reprofiled loan.
There can be no assurance that
such funds will continue to be available on reasonable terms, or at
all in future, and that projects will be completed within the
anticipated timeframes to supplement cashflows through operational
activities. This risk was realised to a significant extent during
2023 where anticipated funding from the Seira and subsequently,
Proventure joint venture agreements, did not materialise and has
delayed the Company's anticipated timeframes for project
completion.
The Group generated revenue of
£737,158 (2023: £341,207) for the period ended 31 December 2024 and
had a net liability position of £1,238,271 (2023: £384 509) as
at 31 December 2024. As at year end, the Group had liquid assets in
the form of cash and cash equivalent and other receivables of
£146,446 and £364,469 (year to 31 December 2023: £122,901),
respectively.
The Directors have reviewed
budgets, projected cash flows and other relevant information, and
based on this review and the rationale set out below, they are
confident that the Group will have adequate financial resources to
continue in operational existence for the foreseeable
future.
The budgets and projected cash
flows are reliant on continued successful drawdowns on current loan
facilities, as well as continued operation of Pyebridge and its
anticipated revenue generation from electricity production.
Unforeseen challenges with either of the aforementioned cause a
risk that the Company may not be able to meet its current
liabilities without another cash injection. The directors have
concluded that the combination of these circumstances represents a
material uncertainty that casts significant doubt upon the Group's
ability to continue as a going concern and that, therefore, the
Group may be unable to realise its assets and discharge its
liabilities in the normal course of business.
The Directors continue to review
the Group's options to secure additional funding for its general
working capital requirements as well as project financing for
commercial production-ready sites, alongside its ongoing review of
anticipated revenue generation from existing sites, potential
acquisition targets and corporate development needs. The Directors
are confident that such funding will be available, although there
is no guarantee of such funding. In addition, any equity funding
may be subject to shareholder approvals and in line with legal and
regulatory requirements as appropriate.
As a result, the Directors
continue to monitor and manage the Group's cash and overheads
carefully in the best interests of its shareholders and believe
that the Company and the Group by successfully implementing the
above responses it will remain a going concern for the foreseeable
future.
Regulatory risk
The United Kingdom power sector
has undergone several considerable regulatory changes over the last
few years and is now at a state of transition from large
fossil-fuel plants to a more diverse range of power-generation
sources, including renewables, small, distributed plants and new
nuclear. As a result, there is greater regulatory involvement in
the structure of the UK power market than has been the case over
the last 20 years. Therefore, there remains a risk that future
interventions by Ofgem or Government could have an adverse impact
on the underlying assets that the Group manages and/or owns. The
Company continually monitors this risk and, where possible, acts
proactively to anticipate and mitigate any regulatory changes that
may have an adverse impact on the ongoing financial viability of
its projects. To monitor compliance with evolving UK government
energy regulations, the Company subscribes to relevant
environmental and energy regulation bodies' updates which
management reviews on a regular basis. It makes recommendations to
the Board in terms of mitigation that may be required should it
become aware of any pending regulatory changes that may threaten
the economic viability of its projects.
Commodity Risk
The assets that the Group manages
and owns will receive revenue from the sale of energy onto the
wholesale market or to end users at a price linked to the wholesale
power market price. Volatility in power prices going forward will
affect the profitability of the underlying reserve power assets.
For example, the significant reduction in wholesale electricity
prices from 2022 to 2023 resulted in lower electricity prices
received from sales at Pyebridge during the period that it was in
operation during 2023. The Group will also use its skills,
capabilities and knowledge of the UK power market to optimise these
wholesale revenues. The Group's ability to effectively manage price
risk and maximise profitability through trading and risk management
techniques with the assistance of its electricity off-taker and
trading platform provider, Statkraft, will have a considerable
impact on the revenues and returns.
Climate risk
The Board considers Climate Risk
to be a principal risk that may threaten the business viability of
the Company insofar as it informs greater regulatory involvement by
the UK Government in the structure of the UK power market as
discussed under Regulatory Risk above. As the Company
currently relies on the availability and permitted use of natural
gas to fuel its current and planned reserve power sites,
accelerated climate change, and associated adverse weather events
may prompt further restrictions on the use of natural gas by UK
regulators including its phasing out within a shorter period than
the Company currently anticipates. In order to mitigate this
risk, in addition to keeping itself informed of any pending
regulatory risk that may threaten the economic viability of its
projects, the Company will ensure that the engineering design and
location of its projects are amenable to the use of alternative
electricity generating fuels to natural gas e.g. green Hydrogen or
biofuel and at minimum conversion costs should it be required. The
Company will also plan to incorporate alternative renewable energy
projects in its project pipeline such as solar, wind,
waste-to-energy or long-duration storage (battery) do diversify its
project portfolio in response to any accelerated phasing out of
natural gas as an electricity generating fuel. As well as
Climate Risk, the Company also recognises Climate Opportunity and
more details on both are discussed under the Strategy heading in
the Task Force on Climate-related Financial Disclosures (TCFD)
section of this report. The TCFD section, in addition to providing
the information required under the TCFD Framework in compliance
with the Listing Rules also includes the Group's Climate Related
Financial Disclosures (CFD)as required under s414C, s414CA and
s414CB of the Companies Act 2006 (the Act).
Development and Construction Risk
The Group will continue to develop
new project sites that includes obtaining planning permission,
securing land (under option to lease or freehold), and obtaining
gas and grid connections. The Group will also oversee the
construction of these projects where needed.
Risks to project delivery include
damage or disruption to suppliers or to relevant manufacturing or
distribution capabilities due to weather, natural disaster, fire,
terrorism, pandemic, strikes or other reasons that could impair the
Company's ability to deliver projects on time.
Failure to take adequate steps to
mitigate the likelihood or potential impact of development and
construction setbacks, or to effectively manage such events if they
occur, could adversely affect the business or financial results.
There are inherent risks that the Group may not ultimately be
successful in achieving the full development and construction of
every site and sunk costs could be lost. However, the risk is
mitigated as the Group targets shovel-ready sites that adhere to
specific requirements, coupled with an experienced senior
management team.
Staffing and Key Personnel Risks
Personnel are our only truly
sustainable source of competitive advantage and competition for key
skills is intense, especially around science, technology,
engineering and mathematics ('STEM') disciplines. While the Group
has good relations with its employees, these relations may be
impacted by various factors. The Group may not be successful in
attracting, retaining, developing, engaging and inspiring the right
people with the right skills to achieve our growth ambitions, which
is why staff are encouraged to discuss with management matters of
interest and subjects affecting day-to-day operations of the
Group.
Information Technology Risks
The Group relies on information
technology ('IT') in all aspects of its business. Any significant
disruption or failure, caused by external factors, denial of
service, computer viruses or human error could result in a service
interruption, accident or misappropriation of confidential
information. Process failure, security breach or other operational
difficulties may also lead to revenue loss or increased costs,
fines, penalties or additional insurance requirements. The Group
continues to implement more cloud-based systems and processes and
improve cyber security protocols and facilities in order to
mitigate the risk of data loss or business interruption.
Note 18: Use of Estimates and Judgements
The preparation of financial
statements in conformity with IFRS requires management to make
judgements, estimates and assumptions that affect the application
of accounting policies and the reported amounts of assets,
liabilities, income and expenses. The estimates and associated
assumptions are based on historical experience and various other
factors that are believed to be reasonable under the circumstances,
the results of which form the basis of making judgements about
carrying values of assets and liabilities that are not readily
apparent from other sources.
In particular, there are
significant areas of estimation, uncertainty and critical
judgements in applying accounting policies that have the most
significant effect on the amounts recognised in the financial
statements.
Estimation uncertainty:
Information about estimates and
assumptions that may have the most significant effect on
recognition and measurement on assets, liabilities and expenses is
provided below:
Impairment assessment of property plant and equipment and
intangible assets
In applying IAS 36, impairment
assessments are performed whenever events or changes in
circumstances indicate that the carrying amount of an asset or CGU
may not be recoverable. Estimates are made in determining the
recoverable amount of assets which includes the estimation of cash
flows and discount rates used. In estimating the cash flows,
management bases cash flow projections on reasonable and
supportable assumptions that represent management's best estimate
of the range of economic conditions that will exist over the
remaining useful life of the assets. The discount rates used
reflect the current market assessment of the time value of money
and the risks specific to the assets for which the future cash flow
estimates have not been adjusted. Refer to Note 11 of the annual
report for detailed sensitivity analysis related to a potential
change in the key estimation uncertainties inherent in the
impairment assessment.
Useful life of Intangible assets
Amortisation is charged on a
systematic basis over the estimated useful lives of the assets
after taking into account the estimated residual values of the
assets. Useful life is either the period of time over which the
asset is expected to be used or the number of production or similar
units expected to be obtained from the use of the asset.
Estimation uncertainty in the valuation of share-based
instruments in issue
Share-based instruments issued,
such as warrants or options, or payments made require significant
judgment and estimate concerning the method of valuation applied
and key inputs applied respectively. In order to calculate the
charge for share based warrants issued or payments as required by
IFRS 9 and IFRS 2 respectively, the Group makes estimates
principally relating to the assumptions used in its option-pricing
model. Refer to Note 12 for details on valuation of share-based
transactions, including options and warrants granted.
Useful life of Property, plant and
Equipment
The depreciable amounts of assets
are allocated on a systematic basis over their useful lives. In
determining the depreciable amount, management makes assumptions in
respect of the residual value of assets based on the expected
estimated amount that the entity would currently obtain from
disposing the asset, after deducting the estimated costs of
disposal. If an asset is expected to be abandoned, the residual
value is estimated at £nil. In determining the useful lives of
assets, management considers the expected period of use of assets,
expected physical wear and tear, legal or similar limits of assets
such as rights, condition and location of the asset as well as
obsolescence.
Estimation uncertainty in the accrual for variable revenue in
relation to electricity generation
The group's revenue is dependent
on the sale of electricity through an offtake partner based on the
quantity of variable units generated over the course of the year.
The utilisation rate is determined by the offtake partner who in
turn relies on on-demand electricity request from the applicable
service area. The group estimates its accrued revenue based on
preliminary data received from the offtake partner which is
obtained daily from the portal. Upon receipt of the final monthly
invoice, which is usually in time for year-end reporting purposes,
the estimates are updated to the actual values. No estimation
uncertainties exist over fixed amount contracts for management fees
and capacity market revenues.
Critical judgements:
Information about critical
judgements that may have the most significant effect on recognition
and measurement on assets, liabilities and expenses is provided
below:
Going Concern
The Groups liabilities exceed its
assets as at 31 December 2024, mainly due to the loan from the
former ultimate holding company ceded to institutional investments
and convertible loan notes of £849,253 and £854,594 respectively
(2023: loans from related parties £849,253) which contributes
significantly to the material uncertainty related to the going
concern assumption applied in preparation of the financial
statements. Management applies judgement in determining whether or
not the Group is able to continue as a going concern for the
foreseeable future, in identifying the matters which give rise to
the existence of the material uncertainty, and in developing
responses thereto in order to address the risk of material
uncertainty. Refer to note 4 for further information on the going
concern assessment.
Note 19: Financial instruments - Fair value and Risk
Management
The carrying amount of all
financial assets and liabilities approximates the fair value.
Directors consider the carrying value of financial instruments of a
short-term nature, that mature in 12 months or less, to approximate
the fair value of such assets or liability classes.
The carrying values of longer-term
assets are considered to approximate their fair value as these
instruments bear interest at interest rates appropriate to the risk
profile of the asset or liability class.
The Group does not carry any
derivative liabilities in the statement of financial position at
fair value at 31 December 2024.